Termination Decision Document | May 8, 2018 | PAPER | BOARD |
Joint Stipulation to Extend Due Dates 1-31-18 | Jan 31, 2018 | PAPER | PATENT OWNER |
2018-01-29 Joint Motion to Terminate | Jan 29, 2018 | PAPER | PATENT OWNER |
2018-01-29 Joint Request to File Settlement Agreement as Confidential | Jan 29, 2018 | PAPER | PATENT OWNER |
Confidential Exhibit 2066 | Jan 29, 2018 | EXHIBIT | PATENT OWNER |
Joint Stipulation to Extend Due Dates | Jan 8, 2018 | PAPER | PATENT OWNER |
Granting Petitioner's Motions for Pro Hac Vice Admission | Dec 5, 2017 | PAPER | BOARD |
Granting Patent Owner's Motion for Pro Hac Vice Admission | Dec 5, 2017 | PAPER | BOARD |
Patent Owner's Mandatory Notices (11-8-17) IPR2014-01104 | Nov 8, 2017 | PAPER | PATENT OWNER |
Patent Owner's Unopposed Motion for Pro Hac Vice Admission IPR2014-01104 | Nov 8, 2017 | PAPER | PATENT OWNER |
Updated Exhibit List (11-8-17) IPR2014-01104 | Nov 8, 2017 | PAPER | PATENT OWNER |
Exhibit 2064 Declaration of Andrew S. Chalson IPR2014-01104 | Nov 8, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2065 Declaration of Daniel C. Wiesner IPR2014-01104 | Nov 8, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2063 | Nov 7, 2017 | EXHIBIT | PATENT OWNER |
Response to Petitioner's Objections to Evidence IPR2017-01104 | Nov 7, 2017 | PAPER | PATENT OWNER |
Updated Exhibit List IPR2017-01104 | Nov 7, 2017 | PAPER | PATENT OWNER |
Petitioner's UnOpposed Motion for Pro hac Vice | Nov 3, 2017 | PAPER | PETITIONER |
Ex. 1030 Declaration of Charles B. Klein | Nov 3, 2017 | EXHIBIT | PETITIONER |
Ex. 1031 Declaration of Kevin E. Warner | Nov 3, 2017 | EXHIBIT | PETITIONER |
Ex. 1032 Declaration of Eimeric Reig-Plessis | Nov 3, 2017 | EXHIBIT | PETITIONER |
Ex. 1029 Declaration of George C. Lombardi | Nov 3, 2017 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List (as of 11-03-2017). | Nov 3, 2017 | PAPER | PETITIONER |
Objections to Evidence IPR2017-01104 | Oct 24, 2017 | PAPER | PATENT OWNER |
Petitioner's Objections to Evidence | Oct 24, 2017 | PAPER | PETITIONER |
Trial Instituted Document | Oct 10, 2017 | PAPER | BOARD |
Scheduling Order | Oct 10, 2017 | PAPER | BOARD |
Exhibit 2005 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2006 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2007 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2009 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2010 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2011 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2001 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2002 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2003 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2004 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2008 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2013 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2015 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2016 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2012 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2014 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2017 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2018 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2028 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2029 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2030 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2034 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2037 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2019 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2020 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2021 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2023 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2024 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2025 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2026 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2027 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2031 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2032 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2033 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2035 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2036 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2038 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2039 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2040 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2041 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2042 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2043 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2044 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2045 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2046 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2047 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2050 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2051 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2052 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2053 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2054 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2055 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2056 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2057 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2058 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2059 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2060 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2061 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
IPR2017-01104 Preliminary Response 7-12-2017 | Jul 12, 2017 | PAPER | PATENT OWNER |
Power of Attorney | Apr 24, 2017 | PAPER | PATENT OWNER |
Mandatory Notice | Apr 24, 2017 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Apr 12, 2017 | PAPER | BOARD |
Ex. 1007 - Li et al., "Fluorescein Binding to Normal Human Serum Proteins Demonstrated by Equilibrium Dialysis," Arch Ophalmol. vol. 100, 484-87 (March 1982) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1011 - Elan Pharma Int'l Ltd. v. Abraxis BioScience, Inc., Judgment and Verdict Form, No. 06-438-GMS, Dkt. 614 (D. Del. June 16, 2008) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1012 - Elan Pharma Int'l Ltd. v. Abraxis BioScience, Inc., Sixth Day of Trial, No. 06-438-GMS, Dkt. 624 (D. Del. June 9, 2008) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Petitioner's Power of Attorney | Apr 4, 2017 | PAPER | PETITIONER |
Ex. 1001 - Desai et al., U.S. Patent No. 7,812,229 B2 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1004 - Kadima et al., WO 2000/006152, (published Feb. 10, 2000) ("Kadima") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1005 - Liversidge et al., U.S. Patent No. 5,399,363 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1006 - Desai et al., WO 1999/000113, (published Jan. 7, 1999) ("Desai") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1009 - FDA Guideline on Sterile Drug Products Produced by Aseptic Processing (June 1987, reprinted June 1991 and Feb. 1997) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1010 - EMEA Guidance on Manufacture of the Finished Dosage Form (April 1996) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1013 - Elan Pharma Int'l Ltd. v. Abraxis BioScience, Inc., Seventh Day of Trial, No. 06-438-GMS, Dkt. 625 (D. Del. June 10, 2008) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1014 - Grinstaff et al., U.S. Patent No. 5,498,421 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1015 - Patient Information Leaflet, "ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)" (revised May 2007) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1016 - Administrative Documents, New Drug Application No. 21-660 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1018 - Ibrahim et al., "Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel,¿¿¿ Clin Cancer Res. 2002 May; 8:1038-44 ("Ibrahim") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1017 - Damascelli, B et al. "Intraarterial chemotherapy with polyoxyethylated cas-tor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007)," Cancer 2001 Nov; 92(10):2592-2602 ("Damascelli") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1019 - U.S. Application No. 11/553,339, Non-Final Office Action (mailed Apr. 28, 2009) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1022 - U.S. Application No. 11/553,339, Amendment After Final Action Under 37 C.F.R. 1.116 (dated Apr. 14, 2010) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1023 - U.S. Application No. 11/553,339, Declaration of Neil P. Desai Pursuant to 37 C.F.R. 1.132 (dated Apr. 14, 2010) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1026 - Desai et al., U.S. Patent No. 5,916,596 (issued Jun. 29, 1999) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1027 - Remington's Pharmaceutical Sciences,18th Edition, Chapter 85 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1020 - U.S. Application No. 11/553,339, Amendment in Response to Non-Final Office Action (dated Oct. 27, 2009) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1021 - U.S. Application No. 11/553,339, Final Office Action (mailed Dec. 31, 2009) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1024 - U.S. Application No. 11/553,339, Notice of Allowance and Fee(s) Due (mailed June 1, 2010) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1025 - FDA, Approved Drug Products with Therapeutic Equivalence Evaluations (33d ed. 2013) ("Orange Book") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1008 - Physicians' Desk Reference 309, 881-887 (54th ed. 2000) "Taxol
(paclitaxel) Injection" ("Taxol label") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1028 - Camden, U.S. Patent No. 6,177,460 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1003 - Desai et al., U.S. Patent No. 5,439,686 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1002 - Declaration Of Cory J. Berkland, Ph.D. | Apr 4, 2017 | EXHIBIT | PETITIONER |
PETITION FOR INTER PARTES REVIEW | Apr 4, 2017 | PAPER | PETITIONER |